Found 89 matching trials
The Efficacy and Safety of LM-302 in Combination With Candonilimab and Capecitabine for First-Line Treatment in Patients With Unresectable Advanced, Recurrent, or Metastatic CLDN18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 A Phase II Study Evaluating the Efficacy and Safety of LM-302 in Combinatio...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer PHASE2 This study is an exploratory clinical trial to investigate the feasibility ...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study PHASE2 The advent of immunotherapy has changed the treatment landscape for patient...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer PHASE2 The goal of this clinical trial is to investigate the efficacy, safety and ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast Cancer PHASE2 The purpose of this study is to assess the efficacy and safety of Cadonilim...
Show More Location
Shengjing Hospital of China Medical University
Learn More & Join Trial
A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104) N/A This is an observational and non-interventional clinical study that only co...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Cadonilimab in Combination With Ramucirumab for the Treatment of Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy PHASE1 To evaluate the efficacy Cadonilimab in combination with Ramucirumab for th...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of C...
Show More Location
Tianjin Medical University Second Hospital
Learn More & Join Trial
A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of Recurrence PHASE2 This study aims to compare the safety and tolerability of cadonilimab appli...
Show More Location
Guangxi Medical University Cancer Hospital
Learn More & Join Trial